Jung Y. Ghee
Ansan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Spexin-based galanin receptor 2 agonist improves renal injury in mice with type 2 diabetes.
Journal: Animal cells and systems
Published: October 04, 2023
SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes.
Journal: Life (Basel, Switzerland)
Published: February 05, 2023
Pan-Nox inhibitor treatment improves renal function in aging murine diabetic kidneys.
Journal: Kidney research and clinical practice
Published: January 04, 2023
The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models.
Journal: Life (Basel, Switzerland)
Published: November 02, 2022
Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease.
Journal: Life (Basel, Switzerland)
Published: June 16, 2022
A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice.
Journal: Life (Basel, Switzerland)
Published: February 25, 2021
Inhibition of Renal Stellate Cell Activation Reduces Renal Fibrosis.
Journal: Biomedicines
Published: September 28, 2020
SH3YL1 protein as a novel biomarker for diabetic nephropathy in type 2 diabetes mellitus.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: April 27, 2020
LPS-Induced Acute Kidney Injury Is Mediated by Nox4-SH3YL1.
Journal: Cell reports
Published: July 19, 2019
APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: July 04, 2016
Chronic Administration of Visfatin Ameliorated Diabetic Nephropathy in Type 2 Diabetic Mice.
Journal: Kidney & blood pressure research
Published: April 11, 2016
Last Updated: 09/26/2026